Why the study?
The balance between ischemic and bleeding events and their relationship with platelet reactivity on antiplatelet therapy after PCI was not fully evaluated in East Asians.
Does high platelet reactivity increase the risk of MACCE and major bleeding in Japanese patients undergoing PCI?
Does high platelet reactivity increase the risk of MACCE and major bleeding in Japanese patients undergoing PCI?
In Japanese patients undergoing PCI, high platelet reactivity is associated with an increased risk of major adverse cardiac and cerebrovascular events at 1 year, without a significant difference in major bleeding.
Answers are grounded in this paper and cite their sources.
High PRU associated with higher MACCE after PCI in Japanese patients; leaves open whether reactivity testing should guide therapy.
Background The balance between ischemic and bleeding events and their association with platelet reactivity in patients receiving antiplatelet therapy after percutaneous coronary intervention ( PCI ), which differs among regions, is not fully evaluated for East Asians. We examined ischemic/bleeding events and platelet reactivity in Japanese patients undergoing PCI and determined associations between high/low platelet reactivity and clinical outcomes. Methods and Results PENDULUM (Platelet Reactivity in Patients with Drug Eluting Stent and Balancing Risk of Bleeding and Ischemic Event) is a prospective, multicenter registry of Japanese patients with PCI . Primary end points were incidence of first major adverse cardiac and cerebrovascular events ( MACCE ) and first major bleeding events at 12 months post‐ PCI . Platelet reactivity (P2Y 12 reaction unit [PRU ] value) was measured at 12 to 48 hours post‐ PCI ; patients were grouped as having high PRU (>208), optimal PRU (>85 to ≤208), and low PRU (≤85). MACCE and major bleeding occurred in 4.4% and 2.8% of 6267 patients, respectively. The mean±SD PRU value was 182.1±77.1. MACCE was significantly higher in the high PRU (5.7%; n=2227) versus the optimal PRU group (3.6%; n=3002). The hazard ratio (HR) for high PRU versus optimal PRU level was significantly higher for MACCE (adjusted HR, 1.53; 95% CI, 1.14–2.06 [ P =0.004]); stent thrombosis followed the same trend. Incidence of major bleeding did not differ significantly between groups. A high PRU level was significantly associated with MACCE in both patients with and patients without acute coronary syndrome. Conclusions These real‐world data suggest an association between high platelet reactivity and cardiovascular events in Japanese patients undergoing PCI . The trend was the same in both patients with and patients without acute coronary syndrome. REGISTRATION URL : https://www.umin.ac.jp/ctr . Unique identifier: UMIN 000020332.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: